Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.99 USD | +9.91% | -6.73% | -35.94% |
Apr. 09 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
Apr. 09 | Syros Gets Fast Track Label For Tamibarotene to Treat Acute Myeloid Leukemia; Shares Rise | MT |
Financials (USD)
Sales 2024 * | 2.8M | Sales 2025 * | 32.08M | Capitalization | 132M |
---|---|---|---|---|---|
Net income 2024 * | -125M | Net income 2025 * | -120M | EV / Sales 2024 * | 47.1 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.11 x |
P/E ratio 2024 * |
-1.35
x | P/E ratio 2025 * |
-1.49
x | Employees | 68 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.92% |
Latest transcript on Syros Pharmaceuticals, Inc.
1 day | +9.91% | ||
1 week | -6.73% | ||
Current month | -6.73% | ||
1 month | -20.41% | ||
3 months | -27.26% | ||
6 months | +125.79% | ||
Current year | -35.94% |
Managers | Title | Age | Since |
---|---|---|---|
Conley Chee
CEO | Chief Executive Officer | 54 | 21-09-26 |
Nancy Simonian
CEO | Chief Executive Officer | 63 | 12-10-31 |
Jason Haas
DFI | Director of Finance/CFO | 56 | 21-10-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Srini Akkaraju
BRD | Director/Board Member | 56 | 17-06-11 |
Tim Tyson
BRD | Director/Board Member | 71 | 22-09-15 |
Marsha Fanucci
BRD | Director/Board Member | 70 | 15-10-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 4.99 | +9.91% | 151,987 |
24-04-19 | 4.54 | -3.81% | 262,916 |
24-04-18 | 4.72 | -7.63% | 119,453 |
24-04-17 | 5.11 | -8.09% | 126,079 |
24-04-16 | 5.56 | +3.93% | 287,406 |
Delayed Quote Nasdaq, April 22, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.94% | 132M | |
-0.02% | 42.11B | |
+43.29% | 40.08B | |
+5.04% | 40B | |
-11.32% | 26.87B | |
+5.25% | 24.58B | |
-23.83% | 18.44B | |
-1.62% | 11.94B | |
+22.75% | 11.66B | |
+6.44% | 11.01B |
- Stock Market
- Equities
- SYRS Stock